UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                      WASHINGTON, DC  20549


                            FORM 10-Q

   (MARK ONE) QUARTERLY REPORT / X / OR TRANSITION REPORT /  /
               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934



For the quarter ended
January 31, 2000                       Commission File No. 1-5865



                     GERBER SCIENTIFIC, INC.
                ---------------------------------
                   (Exact name of Registrant as
                    specified in its charter)



           CONNECTICUT                             06-0640743
 -------------------------------              ---------------------
 (State or other jurisdiction of                  (IRS Employer
  incorporation or organization)               Identification No.)


 83 Gerber Road West, South Windsor, Connecticut       06074
------------------------------------------------- ---------------
    (Address of principal executive offices)         (Zip Code)



Registrant's Telephone Number, including area      (860) 644-1551
code                                              ---------------


Indicate  by check mark whether the registrant (1) has filed  all
reports  required  to be filed by Section  13  or  15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports)  and  (2) has been subject  to  such  filing
requirements for the past 90 days.


                     Yes  / X / .   No /    /.

At  January  31, 2000, 22,204,489 shares of common stock  of  the
Registrant were outstanding.

<PAGE 1>

                     GERBER SCIENTIFIC, INC.
                        AND SUBSIDIARIES
            CONTENTS OF QUARTERLY REPORT ON FORM 10-Q

                 Quarter Ended January 31, 2000


                                                             PAGE



Part I - Financial Information

  Item 1. Consolidated Financial Statements:

           Statements of Earnings for the three months
           ended January 31, 2000 and 1999                   2

           Statements of Earnings for the nine months
           ended January 31, 2000 and 1999                   3

           Balance Sheets at January 31, 2000 and
           April 30, 1999                                  4-5

           Statements of Cash Flows for the nine months
           ended January 31, 2000 and 1999                   6

           Notes to Financial Statements                   7-9

           Independent Accountants' Report                  11

  Item 2. Management's Discussion and Analysis of
           Financial Condition and Results of Operations 12-17

  Item 3. Quantitative and Qualitative Disclosures
          About Market Risk                                 18


Part II - Other Information


  Item 5. Other Information                                 19

  Item 6.  Exhibits and Reports on Form 8-K                 20


Signature                                                    21

Exhibit Index                                                22

<PAGE 2>

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS
                           (Unaudited)

--------------------------------------------------------------
                                          Three Months Ended
In thousands (except per share amounts)       January 31,
--------------------------------------- ----------------------
                                           2000        1999
                                        ---------    ---------
Revenue:

  Product sales                         $141,997     $128,852
  Service                                 13,546       11,947
                                        --------     --------
                                         155,543      140,799
                                        --------     --------

Costs and Expenses:

  Cost of product sales                   84,916       74,159
  Cost of service                          7,080        7,250
  Selling, general and administrative     38,534       36,666
  Research and development expenses        7,982        7,682
  Goodwill amortization                    2,103        2,171
                                        --------     --------
                                         140,615      127,928
                                        --------     --------

Operating income                          14,928       12,871

Other income (expense)                       (21)         478
Interest expense                          (2,733)      (2,604)
                                        --------     --------

Earnings before income taxes              12,174       10,745

Provision for income taxes                 3,900        3,700
                                        --------     --------
Net earnings                            $  8,274     $  7,045
                                        ========     ========
Per share of common stock:
  Basic                                 $    .37     $    .31
  Diluted                               $    .37     $    .31

  Dividends                             $    .08     $    .08

Average shares outstanding:
  Basic                                   22,193       22,700
  Diluted                                 22,411       23,058
                     See Accompanying Notes

<PAGE 3>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF EARNINGS
                           (Unaudited)

--------------------------------------------------------------
                                            Nine Months Ended
In thousands (except per share amounts)       January 31,
--------------------------------------- ----------------------
                                           2000        1999
                                        ---------    ---------
Revenue:

  Product sales                         $407,451     $409,010
  Service                                 40,421       36,038
                                        --------     --------
                                         447,872      445,048
                                        --------     --------

Costs and Expenses:

  Cost of product sales                  239,949      239,296
  Cost of service                         21,573       21,270
  Selling, general and administrative    112,068      113,704
  Research and development expenses       24,884       22,955
  Goodwill amortization                    6,353        6,482
                                        --------     --------
                                         404,827      403,707
                                        --------     --------

Operating income                          43,045       41,341

Other income                               1,116        1,675
Interest expense                          (7,604)      (9,114)
                                        --------     --------

Earnings before income taxes              36,557       33,902

Provision for income taxes                12,400       12,400
                                        --------     --------

Net earnings                            $ 24,157     $ 21,502
                                        ========     ========
Per share of common stock:
  Basic                                 $   1.09     $    .95
  Diluted                               $   1.08     $    .93

  Dividends                             $    .24     $    .24

Average shares outstanding:
  Basic                                   22,167       22,721
  Diluted                                 22,450       23,213

                     See Accompanying Notes

<PAGE 4-5>

             GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                   CONSOLIDATED BALANCE SHEETS


---------------------------------------------------------------
                                         January 31,  April 30,
In thousands                               2000         1999
                                        (Unaudited)
--------------------------------------   ----------  ----------
Assets
Current Assets:
 Cash and short-term cash investments     $ 24,367     $ 26,523
 Accounts receivable                       114,119      103,118
 Inventories                                97,683       72,367
 Prepaid expenses                           18,377       23,690
                                          --------     --------
                                           254,546      225,698
                                          --------     --------
Property, Plant and Equipment              162,400      152,374
 Less accumulated depreciation              64,077       61,789
                                          --------     --------
                                            98,323       90,585
                                          --------     --------
Intangible Assets                          246,830      238,777
 Less accumulated amortization              24,947       18,018
                                          --------     --------
                                           221,883      220,759
                                          --------     --------
Other Assets                                 4,193        5,218
                                          --------     --------
                                          $578,945     $542,260
                                          ========     ========
Liabilities and Shareholders' Equity

Current Liabilities:
 Notes payable                            $    695    $      --
 Current maturities of long-term debt           --          193
 Accounts payable                           53,500       48,374
 Accrued compensation and benefits          17,158       18,982
 Other accrued liabilities                  30,350       35,854
 Deferred revenue                            7,545        6,874
 Advances on sales contracts                 3,478        5,721
                                          --------     --------
                                           112,726      115,998
                                          --------     --------
Noncurrent Liabilities:
 Deferred income taxes                       9,255        9,593
 Long-term debt                            193,964      173,338
                                          --------     --------
                                           203,219      182,931
                                          --------     --------

Contingencies and Commitments

Shareholders' Equity:
 Preferred stock, no par value;
  authorized 10,000,000 shares; no
  shares issued                                 --           --
 Common stock, $1.00 par value;
  authorized 65,000,000 shares; issued
  23,004,489 and 22,858,699 shares          23,004       22,859
 Paid-in capital                            42,845       40,255
 Retained earnings                         214,689      195,871
 Treasury stock, at cost (800,000
  shares)                                  (16,450)     (16,450)
 Unamortized value of restricted stock
  grants                                      (641)        (417)
 Accumulated other comprehensive income
  (loss)                                      (447)       1,213
                                          --------     --------
                                           263,000      243,331
                                          --------     --------
                                          $578,945     $542,260
                                          ========     ========


                     See Accompanying Notes

<PAGE 6>


            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
              CONSOLIDATED STATEMENTS OF CASH FLOWS
                            (Unaudited)
----------------------------------------------------------------------
                                                  Nine Months Ended
In thousands                                         January 31,
--------------------------------------------    ----------------------
                                                  2000         1999
                                               ----------   ---------
Cash Provided by (Used for):
Operating Activities:
  Net earnings                                  $ 24,157    $  21,502
  Adjustments to reconcile net earnings to
   cash provided by operating activities:
     Depreciation and amortization                18,665       17,809
     Deferred income taxes                        (1,730)        (382)
     Other non-cash items                            324          178
     Changes in operating accounts, net of
      effects of business acquisitions:
      Receivables                                 (7,310)      (6,963)
      Inventories                                (19,965)       7,322
      Prepaid expenses                             5,638        9,060
      Accounts payable and accrued expenses       (5,564)     (10,901)
                                                --------     --------
Provided by Operating Activities                  14,215       37,625
                                                --------     --------
Investing Activities:
  Additions to property, plant and equipment     (18,091)     (14,369)
  Business acquisitions                          (11,026)    (175,952)
  Intangible and other assets                     (1,156)        (222)
  Other, net                                      (1,660)       1,113
                                                --------     --------
(Used for) Investing Activities                  (31,933)    (189,430)
                                                --------     --------
Financing Activities:
  Purchase of common stock                            --       (4,940)
  Additions of long-term debt                     40,566      186,686
  Repayments of long-term debt                   (20,133)     (24,445)
  Net short-term financing                        (1,497)     (11,963)
  Debt issue costs                                    --         (800)
  Proceeds from issuance of stock                  1,938        2,602
  Dividends on common stock                       (5,312)      (5,458)
                                                --------     --------
Provided by Financing Activities                  15,562      141,682
                                                --------     --------
(Decrease) in Cash and Short-Term
  Cash Investments                                (2,156)     (10,123)
Cash and Short-Term Cash Investments,
  Beginning of Period                             26,523       27,007
                                                --------     --------
Cash and Short-Term Cash Investments,           $ 24,367     $ 16,884
  End of Period                                 ========     ========
                     See Accompanying Notes

<PAGE 7>

            GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                           (Unaudited)

NOTE 1. Basis of Presentation

The accompanying unaudited consolidated financial statements have
been  prepared  in accordance with generally accepted  accounting
principles  for  interim  financial  statements  and   with   the
instructions  to  Form  10-Q and Article 10  of  Regulation  S-X.
Accordingly,  they  do  not include all of  the  information  and
footnotes  required  by generally accepted accounting  principles
for complete financial statements.  In the opinion of management,
all   adjustments  (consisting  of  normal  recurring   accruals)
considered necessary for a fair presentation have been  included.
Operating  results  for the three- and nine-month  periods  ended
January  31,  2000 are not necessarily indicative of the  results
that may be expected for the year ended April 30, 2000.

For  further  information,  refer to the  consolidated  financial
statements and footnotes thereto included in the Company's Annual
Report on Form 10-K for the year ended April 30, 1999.

NOTE 2. Inventories

The classification of inventories was as follows (in thousands):

                                January 31, 2000  April 30, 1999
                                ----------------  --------------
Raw materials & purchased parts    $56,924            $42,097
Work in process                     40,759             30,270
                                   -------            -------
                                   $97,683            $72,367
                                   =======            =======

NOTE 3. Segment Information

                         Three Months Ended   Nine Months Ended
In thousands                January 31,          January 31,
-----------------------  ------------------  -------------------
                           2000      1999      2000      1999
                         --------  --------  --------- ---------
Segment revenue:
 Sign Making &
  Specialty Graphics     $ 75,383  $ 63,833   $216,710  $207,632
 Apparel & Flexible
  Materials                56,302    53,345    161,774   160,047
 Ophthalmic Lens
  Processing               23,858    23,621     69,388    77,369
                         --------  --------   --------  --------
                         $155,543  $140,799   $447,872  $445,048
                         ========  ========   ========  ========

<PAGE 8>

Segment profit:
 Sign Making &
  Specialty Graphics     $  8,815  $  7,830   $ 26,463  $ 25,937
 Apparel & Flexible
  Materials                 6,203     6,644     17,954    19,125
 Ophthalmic Lens
  Processing                1,786       980      4,453     4,263
                         --------  --------   --------  --------
                         $ 16,804  $ 15,454   $ 48,870  $ 49,325
                         ========  ========   ========  ========

A  reconciliation  of  total  segment  profits  to  consolidated
earnings before income taxes is as follows:

                         Three Months Ended   Nine Months Ended
In thousands                 January 31,         January 31,
------------------------ ------------------   -----------------
                           2000       1999      2000      1999
                          --------  --------  --------  --------
Segment profit            $ 16,804  $ 15,454  $ 48,870  $ 49,325
Corporate      expenses,
net of other income/expense (1,897)   (2,105)   (4,709)   (6,309)
                          --------  --------  --------  --------
Earnings before interest
 and taxes                  14,907    13,349    44,161    43,016
Interest expense            (2,733)   (2,604)   (7,604)   (9,114)
                          --------   --------  --------  --------
Earnings before income
 taxes                    $ 12,174  $ 10,745  $ 36,557  $ 33,902
                          ========  ========  ========  ========

There  were no material changes in segment assets or differences
in  the  basis of segmentation since the Company's  last  Annual
Report on Form 10-K.  However, the measure of segment profit was
changed.  In the Company's segment disclosures on Form 10-K  for
the  year  ended  April  30,  1999,  an  allocation  of  general
corporate  expenses  was  included in  the  measure  of  segment
profit.  For the three- and nine-month periods ended January 31,
2000  and  1999,  segment profit is reported as earnings  before
interest, taxes, and general corporate expenses.

<PAGE 9>

NOTE 4. Comprehensive Income

The Company's total comprehensive income was as follows:

                                   Three Months Ended  Nine Months Ended
In thousands                           January 31,        January 31,
---------------------------------   -----------------   ----------------
                                     2000      1999      2000      1999
                                   --------   -------- -------   --------
Net earnings                        $ 8,274    $ 7,045  $24,157   $21,502
Other comprehensive income
(loss):
  Foreign currency
   translation adjustments              (12)     1,511   (1,660)     (324)
                                    -------    -------  -------   -------
  Total comprehensive income        $ 8,262    $ 8,556  $22,497   $21,178
                                    =======    =======  =======   =======

NOTE 5. Earnings Per Share

The  following  table  sets forth the computation  of  basic  and
diluted earnings per share for the periods indicated:

                            Three Months Ended        Nine Months Ended
                               January 31,              January 31,
                         -----------------------  -----------------------
                            2000         1999         2000         1999
                         -----------  ----------- -----------  -----------
Numerator:
 Net Income              $ 8,274,000  $ 7,045,000 $24,157,000  $21,502,000
                         ===========  =========== ===========  ===========
Denominators:
 Denominator for
  basic earnings per
  share--weighted-
  average shares
  outstanding             22,193,140   22,699,682  22,166,749   22,720,640
 Effect of dilutive
  securities:
  Employee stock
   options                   218,037      358,573     283,373      492,430
                         -----------   ---------- -----------  -----------
  Denominator for
   diluted earnings
   per share--adjusted
weighted-average
   shares outstanding     22,411,177   23,058,255  22,450,122   23,213,070
                         ===========   ========== ===========  ===========
Basic earnings per share $       .37  $       .31 $      1.09  $       .95
                         ===========  =========== ===========  ===========
Diluted earnings per
 share                   $       .37  $       .31 $      1.08  $       .93
                         ===========  =========== ===========  ===========

<PAGE 10>

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES

With  respect to the unaudited consolidated financial  statements
of  Gerber Scientific, Inc. and subsidiaries at January 31,  2000
and  for the three- and nine-month periods ended January 31, 2000
and 1999, KPMG LLP has made a review (based on procedures adopted
by  the  American Institute of Certified Public Accountants)  and
not  an  audit,  as  set  forth in their  separate  report  dated
February  16,  2000 appearing on page 11.  That report  does  not
express   an   opinion  on  the  interim  unaudited  consolidated
financial  information.   KPMG  LLP  has  not  carried  out   any
significant  or additional audit tests beyond those  which  would
have  been  necessary  if  their report had  not  been  included.
Accordingly,  such  report  is not a "report"  or  "part  of  the
Registration Statement" within the meaning of Sections 7  and  11
of  the  Securities Act of 1933 and the liability  provisions  of
Section 11 of such Act do not apply.

<PAGE 11>


                 INDEPENDENT ACCOUNTANTS' REPORT


To the Board of Directors and Shareholders of
Gerber Scientific, Inc.


We  have made a review of the consolidated statements of earnings
of  Gerber  Scientific, Inc. and subsidiaries for the three-  and
nine-month  periods  ended  January  31,  2000  and   1999,   the
consolidated statements of cash flows for the nine-month  periods
ended  January  31,  2000 and 1999, and the consolidated  balance
sheet  as  of  January  31,  2000 in  accordance  with  standards
established  by  the  American  Institute  of  Certified   Public
Accountants.   We  have previously audited,  in  accordance  with
generally   accepted  auditing  standards,  and   expressed   our
unqualified  opinion  dated May 26,   1999  on  the  consolidated
financial  statements  for the year ended  April  30,  1999  (not
presented  herein).  The aforementioned financial statements  are
the responsibility of the Company's management.

A review of interim financial information consists principally of
applying  analytical  review procedures  to  financial  data  and
making  inquiries  of  persons  responsible  for  financial   and
accounting  matters.  It is substantially less in scope  than  an
examination  in  accordance  with  generally  accepted   auditing
standards, the objective of which is the expression of an opinion
regarding   the   financial  statements   taken   as   a   whole.
Accordingly, we do not express such an opinion.

Based   on   our  review,  we  are  not  aware  of  any  material
modifications   that   should  be  made   to   the   accompanying
consolidated statements of earnings for the three- and nine-month
periods  ended  January  31,  2000  and  1999,  the  consolidated
statements of cash flows for the nine-month periods ended January
31,  2000  and  1999,  or the consolidated balance  sheet  as  of
January  31,  2000  for them to be in conformity  with  generally
accepted   accounting  principles.  Also,  in  our  opinion   the
information in the accompanying consolidated balance sheet as  of
April 30, 1999 is fairly presented, in all material respects,  in
relation to the consolidated balance sheet from which it has been
derived.




/s/ KPMG LLP


Hartford, Connecticut
February 16, 2000

<PAGE 12>

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

ACQUISITIONS

During  the  first  nine  months  of  fiscal  2000,  the  Company
purchased  three  businesses included  in  its  Sign  Making  and
Specialty  Graphics  operating segment. The acquisitions  totaled
$11.0  million  and  were made utilizing cash  on  hand  and  the
Company's  multi-currency  revolving  credit  facility.    On   a
combined   basis,  these  businesses  had  annualized  sales   of
approximately  $21.0  million.  Each  of  the  acquisitions   was
accounted for as a purchase, and the results of operations of the
acquired companies have been included in the consolidated results
of  the Company from their respective acquisition dates.  The pro
forma net sales and results of operations for these acquisitions,
had  the  acquisitions occurred at the beginning of fiscal  years
2000  and  1999, are not significant, and accordingly,  have  not
been  provided.   The acquisitions included the Graphi-cal  Group
(Australia) in September 1999, R&D Marketing Aktiebolag  (Sweden)
in  November  1999, and SD Trading OY (Finland) in January  2000.
As  a  result of the acquisitions, approximately $7.8 million  in
goodwill  was  recorded  by  the  Company,  which  reflects   the
adjustments necessary to allocate the individual purchase  prices
to  the fair value of assets acquired and liabilities assumed. On
February  1,  2000,  the  Company announced  the  acquisition  of
Technograf  Group  (Australia), which will  be  included  in  the
Company's fourth quarter consolidated results.

FINANCIAL CONDITION

The  Company's ratio of current assets to current liabilities was
2.3  to 1 at January 31, 2000 compared with 1.9 to 1 at April 30,
1999.   Net  working  capital  at January  31,  2000  was  $141.8
million, an increase of $32.1 million from the beginning  of  the
current  fiscal year and largely attributable to higher  accounts
receivable  and  inventory  levels.   The  increase  in  accounts
receivable balances was primarily caused by the higher volume  of
third  quarter  shipments  and the  business  acquisitions.   The
increase  in inventory balances was largely attributable  to  the
rising  backlog  of  new products and the business  acquisitions.
Reduction  of  inventory  and  receivable  balances  represent  a
significant cash flow generation opportunity for the Company.

The  Company's  cash  and investments totaled  $24.4  million  at
January  31, 2000 compared with $26.5 million at the end  of  the
prior  fiscal year.  Operating activities provided $14.2  million
in cash for the nine-month period ended January 31, 2000 compared
with  $37.6 million provided by operating activities for the same
period  last  year.  Cash generated by earnings and the  non-cash
charges  for  depreciation and amortization in this year's  first
nine  months  was  offset  by  higher  accounts  receivable   and
inventory   balances,   as  discussed   above.    Lower   accrued
liabilities balances, due largely to the timing of payments, also
contributed to the use of cash in the first nine months.

<PAGE 13>

The principal non-operating uses of cash in the nine months ended
January  31,  2000  were for additions to  property,  plant,  and
equipment of $18.1 million and the business acquisitions of $11.0
million.  The Technograf acquisition effective February  1,  2000
amounted  to $2.2 million.  The Company anticipates that  capital
expenditures for the current fiscal year will be in the range  of
$23  -  $24 million.  Cash was also used for payment of dividends
of $5.3 million in the first nine months.

The Company's total long-term debt at January 31, 2000 was $194.0
million,  which  was higher than the April 30,  1999  balance  of
$173.5  million.  Net debt (total debt less cash and investments)
was  $170.3 million at January 31, 2000 versus $147.0 million  at
April 30, 1999, as cash was required in the first nine months for
acquisition funding, additions to property, plant, and equipment,
and to finance the growth in inventories and accounts receivable.
The  ratio of net debt to total capital increased to 39.3 percent
at January 31, 2000 from 37.7 percent at April 30, 1999.

RESULTS OF OPERATIONS

Combined  sales  and  service revenue for the three-month  period
ended  January  31, 2000 increased $14.7 million  (10.5  percent)
from  the  prior  year comparable periods and $2.8  million  (0.6
percent)  for  the  nine-month  period  ended  January  31.   The
increase in the third quarter reflected higher product sales  and
service  revenue.  The increase on a year-to-date basis reflected
lower  product  sales  and  higher service  revenue.  The  higher
product  sales  in  this year's third quarter came  predominately
from  the  Sign  Making and Specialty Graphics operating  segment
($10.5  million). Acquisitions represented $5.1  million  of  the
increase,  and products recently introduced, such as new  digital
imaging  systems  and plotters, represented the majority  of  the
remainder.  Higher  product sales in  the  Apparel  and  Flexible
Materials operating segment ($2.6 million) resulted from products
recently  introduced, such as new single-ply cutting systems  and
plotters,  and a rebound in international markets contributed  to
the  year-over-year  increase.  The service revenue  increase  of
$1.6  million  (13.4 percent) in this year's third  quarter  came
from  each  of  the Company's operating segments as  the  Company
continues  its  focus  on improving its service  businesses.  The
factors  noted  above  overcame  the  third  quarter  impact   of
relatively  weaker foreign exchange rates for the translation  of
foreign currency revenue ($5.3 million).

The   lower   product  sales  in  the  nine-month  period   ended
January  31, 2000 were predominantly caused by anticipated  lower
shipments of Ophthalmic Lens Processing equipment ($8.0 million);
the  prior  year  first  quarter  sale  of  certain  distribution
operations  in  the Sign Making and Specialty Graphics  operating
segment ($2.5 million); the impact on sales of relatively  weaker
foreign  currencies ($11.3 million); and some disruption in  this
year's  first  quarter from the implementation of  an  Enterprise
Resource  Planning  (ERP)  system in  the  Apparel  and  Flexible

<PAGE 14>

Materials  operating  segment.  Service  revenue  increased  $4.4
million (12.2 percent) in the nine-month period ended January 31,
2000.   The  largest increase came from the Apparel and  Flexible
Materials  operating  segment  and  was  partly  the  result   of
incentives used to enhance that segment's service business.

The  consolidated  gross profit margin in the three-month  period
ended January 31, 2000 was 40.9 percent, which was lower than the
prior  year  comparable margin of 42.2 percent.  The consolidated
gross  profit margin in the nine-month period ended  January  31,
2000,  was 41.6 percent, which was substantially the same as  the
prior  year  margin  of 41.5 percent.  Gross  profit  margins  on
product  sales  were  lower  than the prior  year  periods  while
margins on service sales were higher.

The  decrease  in product gross profit margins was primarily  the
result   of  weaker  European  currencies.   This  margin  impact
occurred because most of the Company's manufactured products  are
U.S.  dollar  cost-based and sold in Europe  generally  in  local
currencies.  Sales of certain new products introduced  this  year
also  pressured gross profit margins because of higher  costs  on
initial  production runs. These products include newly introduced
digital  imaging  systems and plotters in  the  Sign  Making  and
Specialty  Graphics operating segment.  The increases in  service
gross  profit  margins came from each of the Company's  operating
segments and were the result of concerted efforts to improve  the
Company's service businesses.

Selling,  general, and administrative (S,G,&A) expenses  in  this
year's third quarter increased $1.9 million (5.1 percent) and  in
this  year's  first  nine  months  decreased  $1.6  million  (1.4
percent)  from the prior year comparable periods.   Increases  in
the third quarter came from higher marketing expenses related  to
new  product introductions and from including the S,G,&A expenses
of  the  acquisitions.   The decrease in the  first  nine  months
compared  with  the  prior year reflected cost reduction  actions
taken  in the prior year to resize the Ophthalmic Lens Processing
operating  segment.   Also  contributing  to  the  decrease  were
further  marketing synergies realized by the Company in the  Sign
Making  and  Specialty  Graphics operating  segment  through  the
acquisition of Spandex PLC and in the Ophthalmic Lens  Processing
operating  segment  through  the acquisition  of  Coburn  Optical
Industries,  Inc. Increased marketing expenses  relating  to  new
products  and  the incremental S,G,&A expense of the acquisitions
partially offset these decreases.  S,G,&A expenses were 24.8  and
25.0 percent of sales in this year's third quarter and first nine
months, respectively, down from 26.0 percent and 25.5 percent  in
the prior year comparable periods.

The Company continued to commit significant resources to research
and the development of new products.  R&D spending increased $0.3
million (3.9 percent) in the third quarter and $1.9 million  (8.4
percent)  in the first nine months compared with last  year.  The
increases  were  related to the stepped-up flow of  new  products
from  each  of  the Company's operating segments in  the  current

<PAGE 15>

year.  As a percentage of sales, research and development was 5.1
percent  in  the third quarter and 5.6 percent in the first  nine
months  compared with 5.5 percent and 5.2 percent,  respectively,
in the prior year comparable periods.

The   year-to-year  impact  of  comparatively   weaker   European
currencies  on  earnings was significant in both the  three-  and
nine-month  periods  ended  January 31,  2000.   Had  prior  year
translation  rates  been in effect earnings before  interest  and
taxes would have been higher by approximately $3.0 million in the
third  quarter  and approximately $4.6 million in the  nine-month
period of fiscal 2000.

Interest expense increased $0.1 million in the third quarter  and
decreased  $1.5 million in the first nine months of  the  current
year.    The  increase  in  the  third  quarter  was  caused   by
comparatively  higher  current  year  borrowings  and  a   higher
weighted average interest rate.  The decrease in interest expense
in  this  year's  nine  months was the result  of  lower  average
interest rates in this year's first half compared with the  prior
year.   Most  of  the Company's borrowings were  against  a  $235
million  multi-currency revolving credit facility.  The  interest
rate on these borrowings is based on the London Interbank Offered
Rate  (LIBOR)  for the relevant currency and term plus  a  margin
based  on  the  relationship of the Company's consolidated  total
debt  to  EBITDA (earnings before interest, taxes,  depreciation,
and amortization).

The  provision  rate for income taxes was 32.0  percent  for  the
third quarter and 33.9 percent for the first nine months compared
with  34.4 percent and 36.6 percent in the comparable prior  year
periods and 35.8 percent for the full prior year.  The lower  tax
rates  this  year  were  primarily the result  of  tax  reduction
strategies   involving   the   Company's   wholly-owned   foreign
subsidiaries  and  also the benefits from the  Company's  Foreign
Sales Corporation.

As  a  result of the above, net earnings increased in this year's
third  quarter to $8.3 million or $.37 diluted earnings per share
from  $7.0  million or $.31 diluted earnings per  share  in  last
year's  third  quarter.  For the first nine months, net  earnings
this  year  increased to $24.2 million or $1.08 diluted  earnings
per  share compared with $21.5 million or $.93 per diluted  share
last year.

NEW ACCOUNTING PRONOUNCEMENTS

In  June  1998, the Financial Accounting Standards  Board  (FASB)
issued  Statement No. 133, "Accounting for Derivative Instruments
and  Hedging  Activities" (SFAS 133).  The Statement  establishes
accounting  and  reporting  standards requiring  that  derivative
instruments be recorded in the balance sheet as either  an  asset
or  liability  measured at fair value and that  changes  in  fair
value  be recognized currently in earnings, unless specific hedge
accounting  criteria  are met.  In June  1999,  the  FASB  issued

<PAGE 16>

Statement  No.  137, "Accounting for Derivative  Instruments  and
Hedging  Activities  -  Deferral of the Effective  Date  of  FASB
Statement  No. 133," which delays the required adoption  of  SFAS
133  to  the Company's fiscal year 2002.  The timing of  adoption
and the effect of SFAS 133 on the Company's financial position or
results of operations have not yet been determined.

YEAR 2000

As  disclosed in the Company's Annual Report on Form 10-K for the
year  ended  April 30, 1999, the Company had developed  plans  to
address the possible business risks related to the impact of  the
Year 2000 on its computer systems.  Since entering the Year 2000,
the  Company  has  not experienced any major disruptions  to  its
business  nor  is  it aware of any significant Year  2000-related
disruptions  affecting its customers and suppliers. Although  the
Company  does not anticipate any significant impact due  to  Year
2000  exposures,  it will continue to monitor  critical  systems,
suppliers,  and  customers over the next several months.  Despite
these  efforts,  the  Company can provide no assurance  that  all
supplier   and   customer   Year  2000  compliance   plans   were
successfully  completed in a timely manner, although  it  is  not
currently  aware of any problems that would significantly  impact
its  operations.  Costs incurred to achieve Year  2000  readiness
were not material and were charged to expense as incurred.

FORWARD-LOOKING STATEMENTS

This report on Form 10-Q contains statements which, to the extent
they are not statements of historical or present fact, constitute
"forward-looking  statements" under the  securities  laws.   From
time to time, oral or written forward-looking statements may also
be  included  in other materials released to the  public.   These
forward-looking  statements are intended to provide  management's
current  expectations  or  plans for  the  future  operating  and
financial  performance  of  the  Company,  based  on  assumptions
currently  believed to be valid.  Forward-looking statements  can
be  identified  by the use of words such as "believe,"  "expect,"
"plans,"    "strategy,"   "prospects,"   "estimate,"   "project,"
"anticipate,"  and other words of similar meaning  in  connection
with  a  discussion of future operating or financial performance.
These include, among others, statements relating to:

-    future   earnings  and  other  measurements   of   financial
     performance,
-    future cash flow and uses of cash,
-    the  effect  of  economic downturns or growth in  particular
     regions,
-    the effect of changes in the level of activity in particular
     industries or markets,
-    the scope, nature, or impact of acquisition activity,
-    product developments and new business opportunities,
-    cost reduction efforts,
-    the outcome of contingencies,
-    the impact of Year 2000 issues, and

<PAGE 17>

-    the transition to the use of the euro as a currency.

All  forward-looking statements involve risks  and  uncertainties
that  may  cause actual results to differ materially  from  those
expressed  or  implied  in the forward-looking  statements.   For
additional information identifying factors that may cause  actual
results  to  vary  materially from those stated in  the  forward-
looking  statements,  see the Company's reports  on  Forms  10-K,
10-Q,  and  8-K filed with the Securities and Exchange Commission
from time to time.  The Company's Annual Report on Form 10-K  for
fiscal  year  1999  includes important  information  as  to  risk
factors  in  the "Business" section under the headings "Operating
Segments"  and  "Other  Matters  Relating  to  the  Corporation's
Business as a Whole."

<PAGE 18>

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES
         ABOUT MARKET RISK

No  material  changes  have  occurred  in  the  quantitative  and
qualitative  market risk disclosures for the Company  from  those
presented  in  the Company's Annual Report on Form 10-K  for  the
year ended April 30, 1999.

<PAGE 19>

                   PART II - OTHER INFORMATION

ITEM 5.   OTHER INFORMATION

On  January 6, 2000, the Company issued a press release reporting
the  acquisition  of  SD  Trading OY, a  leading  distributor  of
computerized sign making hardware in Finland.  The terms  of  the
acquisition were not disclosed.

On February 1, 2000, the Company issued a press release reporting
the  acquisition  of Technograf Group, a leading  distributor  of
computerized  sign making systems in Australia and  New  Zealand.
The terms of the acquisition were not disclosed.

<PAGE 20>

                   PART II - OTHER INFORMATION


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a)  Exhibits

     (15)*       Letter  regarding unaudited interim  financial
                 information.
     (27)*       Financial data schedule.


(b)  Reports on Form 8-K

     No  Form  8-K  was filed during the quarter for  which  this
     report is filed.



*Filed herewith.

<PAGE 21>

                            SIGNATURE


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned, thereunto duly authorized.




                               GERBER SCIENTIFIC, INC.
                              ------------------------
                                    (Registrant)




Date:   March 3, 2000       By:  / s / Gary K. Bennett
        ------------------       --------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 (Principal Financial and
                                 Accounting Officer)

<PAGE 22>

                          EXHIBIT INDEX





  Exhibit
   Index                                                     Page
  Number                                                     ----
 --------

   (15)*       Letter regarding unaudited interim financial
               information.
   (27)*       Financial data schedule.







*Filed herewith.